Mohs Micrographic Surgery is an advanced surgical technique used to treat certain types of skin cancer, particularly those with high risk of recurrence or located in cosmetically sensitive areas. Named after its inventor, Dr. Frederic Mohs, this procedure involves systematic removal and examination of thin layers of skin tissue, layer by layer, until no cancer cells are detected under the microscope. Mohs surgery offers high cure rates while preserving as much healthy tissue as possible, making it particularly suitable for tumors on the face, ears, nose, and other delicate areas. The procedure is performed under local anesthesia in an outpatient setting, allowing patients to return home the same day. During Mohs surgery, the surgeon acts as both the surgeon and the pathologist, examining each layer of tissue immediately after removal. This real-time analysis ensures precise removal of cancerous cells while sparing healthy tissue, minimizing scarring and maximizing cosmetic outcomes. After complete removal of the tumor, the surgical site may be left to heal naturally or reconstructed using various techniques such as suturing, skin grafts, or flaps, depending on the size and location of the defect. Mohs Micrographic Surgery is considered the gold standard for treating certain types of skin cancer, including basal cell carcinoma, squamous cell carcinoma, and some forms of melanoma. Its high cure rates and tissue-sparing approach make it a preferred option for many patients and dermatologists worldwide.
Title : Integrating personalized and precision medicine into dermatology clinical practice securing ITS potential to get skin diseases cured and to revolutionize dermatology
Sergey Suchkov, National Center for Human Photosynthesis, Mexico
Title : Global perspectives on skin health: Diversity in dermatology and cosmetology
Dave Ray, Dave Ray Enterprises., United States
Title : How to correct cosmetic procedures gone wrong
Bharti Magoo, Golden Touch Clinic, India
Title : Epitomic analysis revealed pemphigus autoantibodies against the ligand-binding pocket of M3 muscarinic acetylcholine receptor
Sergei A Grando, University of California Irvine, United States
Title : Perspectives on healthy skin aging and pre-aging concepts
Georgios Stamatas, SGS France, France
Title : Efficacy and safety of rituximab versus pulse therapy in immunobullous disorders: A retrospective study
Ravi M Rathod, KMCRI, India
Title : Dermatology and cosmetology through art and history of art
Dechelette Corinne, La Peau Autrement, France
Title : Acne vulgaris and the most popular and new cosmetological treatments
Karolina Chilicka Hebel, University of Opole, Poland
Title : Stem cells in dermatology and cosmetology
Makoto Senoo, Cell Exosome Therapeutics Inc, Japan
Title : Standards, education and application of special cosmetic treatments in cosmetology practice
Elizabeta Popova Ramova, University MIT Skopje, Macedonia, The Former Yugoslav Republic of